Pembrolizumab-induced myocarditis in a patient with malignant mesothelioma: plasma exchange as a successful emerging therapy—case report

Malignant mesothelioma is an aggressive cancer associated with prior exposure to asbestos and dismal prognosis. Immune checkpoint inhibitor therapy is currently approved by the Food and Drug Administration for pre-treated malignant pleural mesothelioma. We describe a 75-year-old patient with dissemi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Lung Cancer Res
Hlavní autoři: Schiopu, Sanziana R. I., Käsmann, Lukas, Schönermarck, Ulf, Fischereder, Michael, Grabmaier, Ulrich, Manapov, Farkhad, Rauch, Josefine, Orban, Martin
Médium: Artigo
Jazyk:Inglês
Vydáno: AME Publishing Company 2021
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947381/
https://ncbi.nlm.nih.gov/pubmed/33718042
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-1095
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky